ADDERALL XR
ADDERALL XR
Approved
DIN Number
02248813
Drug Class
Human
Market Date
Jan 30, 2004
Company
HC
takeda canada inc
Product Information
Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.
Product Details
Health Canada regulatory and product classification information
Regulatory Identifiers
DIN Number02248813
AIG Number0161310006
Classification & Schedule
C
Drug Class
Human
S
Schedule
Schedule G (CDSA I)
A
ATC Code
N06BA01 AMFETAMINE
Product Specifications
Dosage FormCapsule (Extended Release)
Route of AdministrationOral
AHFS Classification28:20.04
Health Canada Classification
ACTIVE INGREDIENTS (1)
MIXED SALTS AMPHETAMINEActive
Strength: 30 MG
Monograph: MIXED SALTS AMPHETAMINE